Dow Swings Higher as Trade War Fears Ease

Facebook stock is sitting out the broader rally

Mar 26, 2018 at 11:47 AM
facebook twitter linkedin

The Dow Jones Industrial Average (DJI) is soaring, as reports the U.S. and China have started tariff negotiations help ease fears of a global trade war that sent the stock market spiraling last week. The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) are also solidly higher at midday, even as Facebook (FB) stock drops into bear-market territory on news the Federal Trade Commission (FTC) is investigating the social media company's privacy practices amid the recent data-harvesting scandal.

Continue reading for more on today's market, including:

  • The VXX chart pattern stock market bulls should be watching, per founder and CEO Bernie Schaeffer.
  • Why Morgan Stanley thinks Microsoft stock can rally another 49%.
  • Plus, Finish Line options bulls cash out; a surging Buffett-backed stock; and the biotech hitting new highs.

midday market stats march 26

Among the stocks with unusual options volume today is Finish Line Inc (NASDAQ:FINL), with more than 9,300 contracts traded -- about 42 times what's typically seen at this point in the day. Buyout buzz has FINL stock up 29.2% at $13.63, and it looks like some options traders are selling to close their now in-the-money April 12 calls for a volume-weighted average price of $1.68. Those who may have initially bought the calls back on Feb. 26 for $0.60 apiece have now nearly tripled their money.

USG Corporation (NYSE:USG) is at the top of the New York Stock Exchange (NYSE) today, after the construction materials company rejected an unsolicited $42 per share takeover offer from Gebr Knauf -- though Warren Buffett's Berkshire Hathaway (BRK.A) offered to sell its 31% stake in USG to the German firm for at least the buyout price. USG stock is up 16.9% to trade at $39.18, after earlier running into a familiar ceiling at the round $40 level.

usg stock daily chart march 26

Verona Pharma (NASDAQ:VRNA) is at the top of the Nasdaq, after the drugmaker reported positive mid-stage study data for its chronic obstructive pulmonary disease (COPD) treatment. VRNA stock is up 46.2% at $23.40, fresh off a record high of $24.43.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners